CIK 0001611747 · Non-accelerated filer
Scinai Immunotherapeutics Ltd.
Sign in to watch- Ticker
- SCNI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972-8-9302529
- Business address
- JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, Israel, 00000
- Former names
- BiondVax Pharmaceuticals Ltd.
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 424B3 Offering Prospectus
- 6-K Event Report of Foreign Issuer
- 20-F Report Annual and Transition Report of Foreign Private Issuers
- 6-K Event Report of Foreign Issuer
- NT 20-F Other Notification of Inability to Timely File
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 6 of 25 · 498 filings